AbbVie cuts 2025 profit forecast on acquisition expenses

Published: 2025-04-03 16:34:48 ET ABBV

(Reuters) -AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses.

The company expects adjusted profit in the range of $11.99 to $12.19 per share, compared with its previous forecast of $12.12 to $12.32 per share.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shreya Biswas)